+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effects of bendazac L-lysine salt on X-ray-induced cataract in the rabbit lens



Effects of bendazac L-lysine salt on X-ray-induced cataract in the rabbit lens



Experimental Eye Research 42(2): 167-175



The effects of bendazac-L-lysine salt (bendazac-lysine) on some biochemical parameters (soluble and insoluble proteins, reduced glutathione, sulphydryl and disulphide groups, water content) in rabbit lens at different times after X-rays (2000 rads) were studied. The mature cataract (swelling and total lens opacity) developed 11-12 weeks after irradiation. In the mature cataract, the irradiated lenses not treated with bendazac-lysine (ILNTB) show a 32% increase in water content compared with controls; this increase is 12% in irradiated lens treated with bendazac-lysine (ILTB). Twelve weeks after irradiation the concentration of insoluble proteins in the controls, ILNTB and ILTB is 7.6%, 52.3% and 18.3% respectively. After 6, 8 and 12 weeks the concentration of reduced glutathione in ILNTB decreases by 23%, 81% and 92% as compared with the controls. In the ILTB the decrease is present only 8 and 12 weeks after X-irradiation and is of 55% and 69%, respectively. The sulphydryl-group content in the soluble proteins in ILNTB compared with the controls decreases by 26%, 38% and 47% after 6, 8 and 12 weeks, while in the ILTB a decrease is observed only after 8 and 12 weeks and is 6% and 12%, respectively. The decrease of the sulphydryl groups parallels the increase of the disulphide groups. This increase is already significant (P less than 0.01) after 6 weeks in the ILNTB, whereas it becomes significant in the ILTB only after 8 weeks.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 039960211

Download citation: RISBibTeXText

PMID: 3699106

DOI: 10.1016/0014-4835(86)90040-0


Related references

Effects of bendazac L-lysine salt on some metabolic enzymes of glutathione in the rabbit lens after X-irradiation. Italian Journal of Biochemistry 36(3): 153-165, 1987

Critical evaluation of bendazac lysine salt in the treatment of cataract. Bollettino di Oculistica 63(11-12): 1271-1282, 1984

Basic data supporting the use of the l-lysine salt of bendazac in cataract. International Journal of Tissue Reactions 5(2): 217-225, 1983

Bendazac prevents cyanate binding to soluble lens proteins and cyanate-induced phase-separation opacities in vitro: a possible mechanism by which bendazac could delay cataract. Experimental Eye Research 43(6): 973-979, 1986

Treatment of early cortical cataract experience with bendazac lysine salt. Prensa Medica Argentina 72(11): 380-383, 1985

Inhibition of rat lens aldose reductase by bendazac-L-lysine salt. Enzyme 42(4): 235-237, 1989

New methods for studying lens opacities results of a double blind pilot study on the effect of bendazac lysine in senile cataract. Annali di Ottalmologia e Clinica Oculistica 111(12): 1085-1102, 1985

Controlled clinical evaluation of bendazac lysine in senile cataract a multicenter study analysis of the effects of 6 months treatment. Bollettino di Oculistica 64(1-2): 71-88, 1985

Bendazac Lysine in Selected Types of Human Senile Cataract. Ophthalmic Research 21(3): 141-154, 1989

Effect of bendazac lysine on lens and retina in diabetics. Documenta Ophthalmologica. Advances in Ophthalmology 86(4): 387-393, 1994

Hepatotoxicity due to lysine salt of bendazac. Scandinavian Journal Of Gastroenterology. 31(2): 206-208, 1996

Senile and presenile cataract therapy with bendazac lysine a clinical evaluation. Bollettino di Oculistica 65(4): 671-684, 1986

Clinical evaluation of topical bendazac lysine in treatment of senile cataract. Bollettino di Oculistica 67(1): 25-30, 1988

Clinical trial of bendazac lysine eye drops in the medical treatment of cataract. Bollettino di Oculistica 68(5): 823-834, 1989

Clinical study of bendazac lysine for in vivo contact lens cleaning. Optometry and Vision Science 70(3): 210-215, 1993